Effect of chromium supplementation on insulin resistance and ovarian and menstrual cyclicity in women with polycystic ovary syndrome

R. Scott Lucidi; Angela C. Thyer; Carol A. Easton; Alan E Holden; Robert S. Schenken; Robert G. Brzyski

doi:10.1016/j.fertnstert.2005.06.028

Effect of chromium supplementation on insulin resistance and ovarian and menstrual cyclicity in women with polycystic ovary syndrome

R. Scott Lucidi
, Angela C. Thyer
, Carol A. Easton
, Alan E Holden
, Robert S. Schenken
, Robert G. Brzyski

Department of Obstetrics & Gynecology

Research output: Contribution to journal › Article › peer-review

37 Scopus citations

Abstract

In women with polycystic ovary syndrome, chromium picolinate (200 μg/d) improves glucose tolerance compared with placebo but does not improve ovulatory frequency or hormonal parameters. This pilot study indicates that future studies in the polycystic ovary syndrome population should examine higher dosages or longer durations of treatment.

Original language	English (US)
Pages (from-to)	1755-1757
Number of pages	3
Journal	Fertility and sterility
Volume	84
Issue number	6
DOIs	https://doi.org/10.1016/j.fertnstert.2005.06.028
State	Published - Dec 2005

ASJC Scopus subject areas

Reproductive Medicine
Obstetrics and Gynecology

Access to Document

10.1016/j.fertnstert.2005.06.028

Cite this

@article{caffcfd41ec74d42aad0e08c33a38a56,

title = "Effect of chromium supplementation on insulin resistance and ovarian and menstrual cyclicity in women with polycystic ovary syndrome",

abstract = "In women with polycystic ovary syndrome, chromium picolinate (200 μg/d) improves glucose tolerance compared with placebo but does not improve ovulatory frequency or hormonal parameters. This pilot study indicates that future studies in the polycystic ovary syndrome population should examine higher dosages or longer durations of treatment.",

author = "Lucidi, \{R. Scott\} and Thyer, \{Angela C.\} and Easton, \{Carol A.\} and Holden, \{Alan E\} and Schenken, \{Robert S.\} and Brzyski, \{Robert G.\}",

year = "2005",

month = dec,

doi = "10.1016/j.fertnstert.2005.06.028",

language = "English (US)",

volume = "84",

pages = "1755--1757",

journal = "Fertility and sterility",

issn = "0015-0282",

publisher = "Elsevier Inc.",

number = "6",

}

TY - JOUR

T1 - Effect of chromium supplementation on insulin resistance and ovarian and menstrual cyclicity in women with polycystic ovary syndrome

AU - Lucidi, R. Scott

AU - Thyer, Angela C.

AU - Easton, Carol A.

AU - Holden, Alan E

AU - Schenken, Robert S.

AU - Brzyski, Robert G.

PY - 2005/12

Y1 - 2005/12

N2 - In women with polycystic ovary syndrome, chromium picolinate (200 μg/d) improves glucose tolerance compared with placebo but does not improve ovulatory frequency or hormonal parameters. This pilot study indicates that future studies in the polycystic ovary syndrome population should examine higher dosages or longer durations of treatment.

AB - In women with polycystic ovary syndrome, chromium picolinate (200 μg/d) improves glucose tolerance compared with placebo but does not improve ovulatory frequency or hormonal parameters. This pilot study indicates that future studies in the polycystic ovary syndrome population should examine higher dosages or longer durations of treatment.

UR - https://www.scopus.com/pages/publications/28944448773

UR - https://www.scopus.com/pages/publications/28944448773#tab=citedBy

U2 - 10.1016/j.fertnstert.2005.06.028

DO - 10.1016/j.fertnstert.2005.06.028

M3 - Article

C2 - 16359984

AN - SCOPUS:28944448773

SN - 0015-0282

VL - 84

SP - 1755

EP - 1757

JO - Fertility and sterility

JF - Fertility and sterility

IS - 6

ER -

Effect of chromium supplementation on insulin resistance and ovarian and menstrual cyclicity in women with polycystic ovary syndrome

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this